Latest Blogs

May 22, 2018
Sometimes cross-coverage means having hard conversations with patients who aren't ours, but who still deserve our expertise and our honesty.
May 21, 2018
"I know too much. I don't know enough." Dr. Stephanie L. Graff interviews Dr. Kelly Shanahan, an OB/GYN living with metastatic breast cancer.
May 18, 2018
At a forum on work-life balance, Dr. Julia Close was asked, "When is the best time to have children?" There's no easy answer to this question.
May 17, 2018
ASCO would like to inform you of some changes to MOC that are a direct result of your input and our open, transparent collaboration with the ABIM. 
Subscribe to this column

Bruce E. Johnson, MD, FASCO

Bruce E. Johnson, MD, FASCO, is the 2017-2018 ASCO President. He is chief clinical research officer and institute physician at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Dana-Farber/Harvard Cancer Center (DF/HCC) Lung Cancer Program. He served as director of the Lowe Center for Thoracic Oncology from 1998 through 2013.
 
An ASCO member since 1985, Dr. Johnson has served in numerous volunteer and leadership roles, including the Board of Directors (2008-2011), Chair of the Audit, Cancer Education, and Cancer Communications Committees, and on the Journal of Clinical Oncology Editorial Board, among other positions. In 2008, he was awarded the Translational Research Professorship from the Conquer Cancer Foundation of ASCO; in 2012, he was elected as a Fellow of ASCO (FASCO).

May 21, 2018
Take the survey today and help shape the future of cancer care.
May 18, 2018
As the ASCO Annual Meeting approaches, I discuss the theme that I selected for the meeting and for my presidential term.
May 14, 2018
Our Annual Meeting features the brightest minds of oncology, and provides a matchless opportunity to network with our colleagues from the United States and around the world. 
Dec 21, 2017
ASCO urges Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.
Dec 01, 2017
We are committed to supporting and promoting practical policy solutions that ensure patients with cancer have access to, and can afford, drugs vital to their treatment.
Jul 11, 2017
The price of and access to oncology drugs remains both a national and international challenge to our patients, providers, and third-party payers.

Pages